Pathak Namyata
Integrative Ayurveda Specialist, Ayu.Care Clinic, San Francisco Bay Area, California and Education Chair, California Association of Ayurvedic Medicine, Fremont, CA, United States.
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100468. doi: 10.1016/j.jaim.2021.06.008. Epub 2021 Jun 18.
The crisis of the second wave of COVID-19 in India is anticipated to peak over the next few weeks, stressing the healthcare system further. India has the unique strength of AYUSH with access to safe traditional medications, certain scientifically validated interventions, a highly skilled resource pool of nationwide vaidyas who are willing to engage with its leadership. The excellent foundations laid for COVID-19 response by AYUSH can be further developed to empower people and the vaidyas. The current guidelines are based on classical references, biological plausibility and scientific studies done in a conventional mode. It is now an opportune time to document clinical observations, identify symptom specific interventions and engage with mainstream management to evolve Integrative Ayurveda guidelines for COVID-19 management. This article discusses the premise and the details of the next steps. There is a hope that a conducive environment created by AYUSH will alter the landscape of Integrative Medicine and health in India, inspiring global health practices.
预计印度第二波新冠疫情危机将在未来几周达到顶峰，这将进一步给医疗系统带来压力。印度拥有阿育吠陀这一独特优势，可获取安全的传统药物、某些经过科学验证的干预措施，还有一批技术精湛、愿意参与领导工作的全国范围内的吠陀医生资源库。阿育吠陀为应对新冠疫情奠定的良好基础可进一步发展，以增强民众和吠陀医生的能力。当前的指南基于经典参考文献、生物学合理性以及以传统方式开展的科学研究。现在是记录临床观察结果、确定针对特定症状的干预措施并与主流治疗相结合，以制定阿育吠陀综合新冠疫情管理指南的恰当时机。本文讨论了这一前提及后续步骤的细节。人们希望阿育吠陀营造的有利环境将改变印度综合医学与健康的局面，并激励全球的健康实践。
